BSL-3 Practices Core
BSL-3 实践核心
基本信息
- 批准号:10793829
- 负责人:
- 金额:$ 76.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-18 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAdoptedAdoptionAerosolsAreaAttentionAuthorization documentationBasic ScienceCOVID-19CertificationCommunicable DiseasesCommunitiesCompetenceComplementContainmentContinuing EducationCore FacilityDecontaminationDiagnosticEmergency SituationEmergency responseEmerging Communicable DiseasesEnvironmentEquipmentEquipment and supply inventoriesExerciseFacultyFaculty RecruitmentFailureFamily suidaeGoalsGrantHuman ResourcesIndividualInfectious Diseases ResearchInfluenzaInfrastructureInternationalInvestigationInvestmentsLaboratoriesLocationMaintenanceMethodologyMissionMissouriModernizationMutant Strains MiceNational Institute of Allergy and Infectious DiseaseOperations ResearchPlayPositioning AttributePrecision HealthPrevention strategyPrincipal InvestigatorProceduresProductivityPublic HealthPublic Health SchoolsRattusReadinessReportingResearchResearch PersonnelResearch SupportResource DevelopmentResourcesRisk AssessmentRoleSafetyScienceSecurityServicesStandardizationStudentsTeaching HospitalsTestingTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthUniversitiesVaccinesVariantVector-transmitted infectious diseaseWorkWorkforce Developmentauthoritybasebiocontainment facilitybiosafety level 3 facilityemerging pathogenimprovedinnovationinsightinstitutional biosafety committeeinstrumentationinterestmedical schoolsmeetingsnew technologyoperationpandemic preparednesspandemic responsepathogenpriority pathogenprogramsrecruitresearch and developmentresearch facilityskills
项目摘要
Project Summary
Core 2: Biosafety Level 3 Practices
The Biosafety Level 3 Practices Core (BPC) at the Laboratory of Infectious Disease Research (LIDR)
includes three major components: Biosafety and emergency planning, user training and competency oversight,
and select agent program management. The BPC is integrated within the LIDR program and is positioned to
provide LIDR researchers from across campus with BSL-3 training and resources for working with BSL-3
pathogens. The LIDR is administered under the direction of the Division of Research, Innovation and Impact.
The goals of the BPC are to facilitate and support research by offering professional user training, scientific
procedural oversight, and to advise on all matters related to the scientific program including facility compliance
and safety. To achieve this goal, the BSL-3 Practices Core interfaces with all aspects of LIDR, including building
and facility infrastructure, security, laboratory practices, decontamination, and, importantly, the BPC oversees
the compliance of the BSL-3/select agent program as well as initial and ongoing training of its users. Towards
these goals, the LIDR Biosafety Level 3 Practices Core oversees compliance for working with select agents,
including the LIDR Personnel Suitability and Reliability Program (PSRP). For individuals cleared for entry into
the LIDR, the BSL-3 Practices Core will provide a comprehensive initial and ongoing competency-based training
program, and will be responsible for certifying the readiness of all individuals for entering BSL-3/ACL-3/ABSL-3
laboratories and associated support spaces. In addition, the BSL-3 Practices Core manages emergency
response planning, as well as drills, exercises and after-action reports, investigations and corrective action plans
for the BSL-3 program at LIDR. To maximize efficiencies and adoption of best practices, the BSL-3 Practices
Core is committed to workforce development by offering continuing education and certifications for
biocontainment professionals. Further, the BSL-3 Practices Core will work closely with Core 1 and Core 3 in this
UC7 project to train professional staff in the biosafety, biocontainment, and the safe operations of aerosol-
generating instrumentation. The BSL-3 Practices Core interacts closely with the Institutional Biosafety
Committee, Principal Investigators, the LIDR Operations Committee, and the RBL-NBL network to develop and
adopt best practice standard operating procedures and conduct risk assessments for all work associated with
BSL-3 pathogens. The BSL-3 Practices Core plays a central role in the pandemic preparedness and response
of the LIDR to facilitate its contributions to meeting the needs of emerging infectious diseases. Overall, the BSL-
3 Practices Core enables the work performed at LIDR, and assures that the BSL-3 Cores for the Facility
Operations and Research Resources can carry out their objectives for high containment research without
harming themselves, the environment or community.
项目摘要
核心2:生物安全3级实践
传染病研究实验室生物安全3级实践核心(BPC)
包括三个主要组成部分:生物安全和应急规划、用户培训和能力监督,
并选择代理程序管理。BPC集成在LIDR计划中,并定位为
为来自校园的LIDR研究人员提供BSL-3培训和使用BSL-3的资源
病原体。LIDR在研究、创新和影响司的指导下管理。
BPC的目标是通过提供专业的用户培训、科学的
程序监督,并就与科学计划有关的所有事项提供咨询,包括设施合规
和安全。为了实现这一目标,BSL-3实践了与LIDR的所有方面的核心接口,包括建立
和设施基础设施、安全、实验室实践、净化,以及更重要的是,BPC监督
BSL-3/SELECT代理商计划的合规性以及对其用户的初步和持续培训。朝向
这些目标,LIDR生物安全3级实践核心监督与选定代理合作的合规性,
包括LIDR人员适宜性和可靠性计划(PSRP)。对于获准进入的个人
LIDR,即BSL-3实践核心,将提供基于能力的全面初始和持续培训
计划,并将负责认证所有个人进入BSL-3/ACL-3/ABSL-3的准备情况
实验室和相关的支持空间。此外,BSL-3实践核心管理紧急情况
应对规划以及演习、演习和行动后报告、调查和纠正行动计划
用于LIDR的BSL-3计划。为了最大限度地提高效率和采用最佳实践,BSL-3实践
CORE致力于通过为以下人员提供继续教育和认证来促进劳动力发展
生物遏制专业人士。此外,BSL-3实践核心将在这方面与核心1和核心3密切合作
UC7项目旨在培训有关生物安全、生物遏制和气雾剂安全操作的专业人员-
正在生成工具。BSL-3实践核心与机构生物安全密切互动
委员会、首席调查员、激光雷达业务委员会和RBL-NBL网络,以开发和
采用最佳实践标准操作程序,并对与以下各项相关的所有工作进行风险评估
BSL-3病原菌。BSL-3实践核心在大流行防备和应对中发挥着核心作用
LIDR的作用是促进其为满足新出现的传染病的需要作出贡献。总体而言,BSL-
3实践核心支持在LIDR执行的工作,并确保设施的BSL-3核心
运营和研究资源可以实现其高遏制研究目标,而无需
损害自己、环境或社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY Joseph ADAMOVICZ其他文献
JEFFREY Joseph ADAMOVICZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 76.81万 - 项目类别:
Research Grant














{{item.name}}会员




